Integral Ad Science Holding (IAS)
(Real Time Quote from BATS)
$10.51 USD
-0.82 (-7.24%)
Updated Aug 5, 2024 10:14 AM ET
1-Strong Buy of 5 1
D Value C Growth A Momentum C VGM
Income Statements
Fiscal Year end for Integral Ad Science Holding Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 474 | 408 | 324 | 241 | 213 |
Cost Of Goods | 99 | 76 | 55 | 41 | 33 |
Gross Profit | 375 | 333 | 269 | 200 | 180 |
Selling & Adminstrative & Depr. & Amort Expenses | 358 | 317 | 302 | 214 | 214 |
Income After Depreciation & Amortization | 17 | 15 | -33 | -14 | -34 |
Non-Operating Income | 0 | 7 | -4 | 0 | 0 |
Interest Expense | 12 | 9 | 19 | 32 | 33 |
Pretax Income | 5 | 13 | -56 | -45 | -67 |
Income Taxes | -2 | -2 | -4 | -13 | -15 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 7 | 15 | -52 | -32 | -51 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 7 | 15 | -52 | -32 | -51 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 73 | 66 | 30 | 53 | 38 |
Depreciation & Amortization (Cash Flow) | 55 | 51 | 63 | 67 | 72 |
Income After Depreciation & Amortization | 17 | 15 | -33 | -14 | -34 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 161.72 | 157.26 | 143.54 | NA | NA |
Diluted EPS Before Non-Recurring Items | 0.04 | 0.10 | -0.31 | NA | NA |
Diluted Net EPS (GAAP) | 0.04 | 0.10 | -0.37 | NA | NA |
Fiscal Year end for Integral Ad Science Holding Corp falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 129.01 | 114.53 | 134.30 | 120.33 | 113.65 |
Cost Of Goods | 27.09 | 26.16 | 28.25 | 25.60 | 23.82 |
Gross Profit | 101.91 | 88.37 | 106.04 | 94.73 | 89.83 |
SG&A, R&D, and Dept/Amort Expenses | 87.77 | 87.83 | 89.53 | 85.53 | 108.04 |
Income After SG&A, R&D, and Dept/Amort Expenses | 14.14 | 0.54 | 16.51 | 9.20 | -18.21 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 1.54 | 1.93 | 2.49 | 3.11 | 3.22 |
Pretax Income | 12.61 | -1.39 | 14.02 | 6.09 | -21.43 |
Income Taxes | 4.92 | -0.13 | 3.86 | 19.84 | -29.11 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 7.69 | -1.26 | 10.16 | -13.75 | 7.68 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 7.69 | -1.26 | 10.16 | -13.75 | 7.68 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 163.75 | 159.39 | 163.06 | 157.06 | 162.63 |
Diluted EPS Before Non-Recurring Items | 0.05 | -0.01 | 0.06 | -0.09 | 0.05 |
Diluted Net EPS (GAAP) | 0.05 | -0.01 | 0.06 | -0.09 | 0.05 |